Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Thrombosis
Biotech
Cadrenal launches strategic review for cardiology pipeline
The biotech’s board is weighing options that could include selling drug candidates, partnering with other companies or even pursuing a merger.
Darren Incorvaia
Oct 7, 2026 12:54pm
Hemab uses $135M series B to target neglected blood disorders
Feb 21, 2023 4:07am
Easing blood clotting through a new pathway
Jan 11, 2022 7:10am
Hemab raises $55M to target multiple rare bleeding indications
Jul 22, 2021 3:00am
Abbott racks up 2 new U.S., EU approvals for Xience stents
Jul 1, 2021 9:53am
New discoveries in eye regeneration and blood clots—News of Note
Aug 28, 2017 3:48pm
